On August 14, 2026, China's National Healthcare Security Administration released a trial guide that sets a single national price framework for lab tests such as blood and urine panels, ending decades of region-by-region, method-by-method billing.

One Ruler for the Whole Country: Unified Pricing for Medical Lab Tests

Across China, the price of a single routine lab test once varied from hospital to hospital and from province to province. On August 14, 2026, the National Healthcare Security Administration (NHSA) released the Guiding Catalogue for Pricing of Laboratory Medical Services (Trial), establishing one national framework for tests such as the complete blood count and the routine urine analysis. In the language of the authorities, lab services finally have a single ruler for the whole country.

The Methodology Problem

The guide tackles a long-standing pricing oddity: the same clinical indicator was often billed differently depending on the laboratory method used to measure it. A blood-glucose test, for example, could appear as several separate charge items — dry-chemistry method, enzyme method, enzyme-electrode method — each with a different price, even though the result a patient receives is one and the same. Under the new framework, a single indicator is in principle no longer split into multiple main items by method; glucose testing becomes one charge, glucose testing fee, and the principle is same test, same price.

How Fine-Grained the Items Are

The catalogue balances clinical habit against the pace of technology. Common, well-understood high-frequency items such as folic-acid testing and nucleic-acid testing for hepatitis B and C are set up as standalone items. For fast-moving categories such as autoantibodies, where indicators multiply quickly, the guide groups items by disease class so the catalogue does not have to be rewritten every time a new assay appears. The NHSA says this is part of a broader program to unify medical-service pricing nationwide, with roughly 180 additional forward-looking items for new technologies and products already introduced across earlier batches.

Why It Matters as Knowledge

The innovation is billing logic: price follows the clinical question answered, not the technical route used to answer it.
Pricing is set at the national level, which reduces information asymmetry between patients and hospitals and makes out-of-pocket costs easier to compare.
Standardized items also make it easier for medical insurance to pay by disease category and for lab networks to scale.

When the price of a test stops depending on how it was run and starts depending on what it tells you, the healthcare system has moved one step closer to treating a lab result as a service rather than a bundle of procedures.